Cart
sales@molnova.com
GS967
CAS No. 1262618-39-2
GS967( GS967 | GS-967 | GS 967 | GS458967 )
Catalog No. M11095 CAS No. 1262618-39-2
GS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 27 | In Stock |
|
| 5MG | 43 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 146 | In Stock |
|
| 50MG | 268 | In Stock |
|
| 100MG | 470 | In Stock |
|
| 200MG | 680 | In Stock |
|
| 500MG | 1053 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGS967
-
NoteResearch use only, not for human use.
-
Brief DescriptionGS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa).
-
DescriptionGS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa); inhibits ATX-II-induced late I(Na) in ventricular myocytes and isolated hearts with IC(50) values of 0.13 and 0.21 μM, respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsGS967 | GS-967 | GS 967 | GS458967
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
Recptorlate?INa?,isolated hearts| late?INa?,ventricular myocytes
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number1262618-39-2
-
Formula Weight347.22
-
Molecular FormulaC14H7F6N3O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESFC(C1=NN=C2C=CC(C3=CC=C(OC(F)(F)F)C=C3)=CN21)(F)F
-
Chemical Name6-(4-(trifluoromethoxy)phenyl)-3-(trifluoromethyl)(1,2,4)triazolo(4,3-a)pyridine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Belardinelli L, et al. J Pharmacol Exp Ther. 2013 Jan;344(1):23-32.
molnova catalog
related products
-
DS-1971a
DS-1971a is a highly potent and selective NaV1.7 inhibitor. DS-1971a exhibits a favorable toxicological profile and analgesic effects.
-
5-Tridecanol
5-Tridecanol blocks ion flux in sodium channels.
-
Eleclazine hydrochlo...
A novel, potent, and selective inhibitor of Late sodium current (late INa) for treatment of long QT-3 syndrome (LQT-3).
